Prosecution Insights
Last updated: November 04, 2026
Application No. 17/968,327

Hypodermic Interface Assembly

Non-Final OA §103
Filed
Oct 18, 2022
Priority
Jul 28, 2020 — CIP of 11/938,309
Examiner
SCHMIDT, EMILY LOUISE
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Neogen Corporation
OA Round
3 (Non-Final)
58%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
595 granted / 1018 resolved
-11.6% vs TC avg
Strong +37% interview lift
Without
With
+36.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
60 currently pending
Career history
1103
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
21.9%
-18.1% vs TC avg
§112
22.3%
-17.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1018 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on June 3, 2026 has been entered. Priority Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Applicant has not complied with one or more conditions for receiving the benefit of an earlier filing date under 35 U.S.C. 120 as follows: The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application). The disclosure of the invention in the parent application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or the first paragraph of pre-AIA 35 U.S.C. 112, except for the best mode requirement. See Transco Products, Inc. v. Performance Contracting, Inc., 38 F.3d 551, 32 USPQ2d 1077 (Fed. Cir. 1994). The disclosure of the prior-filed application, Application No. 16/947,305, fails to provide adequate support or enablement in the manner provided by 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph for one or more claims of this application. The prior filed application does not disclose a core. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-10 and 12 is/are rejected under 35 U.S.C. 103 as being unpatentable over Satchell (US 3,736,932) in view of Schraga (US 2012/0123334 A1) and Monson et al. (US 2009/0312715 A1). With regard to claim 1-9 and 12, Satchell teaches a hypodermic interface assembly comprising: a hub having a distal-most end surface (Fig. 4 member 52); a core member defined by a body having a proximal end having a proximal end surface and a distal end having a distal end surface (not numbered structure inserted into the distal end of 54 surrounding the cannula); a cannula, wherein a portion of the cannula extends in a distal direction from the distal-most end surface of the hub to and in a proximal direction from the proximal end surface of the proximal end of the body of the core member, and wherein the distal-most end surface of the hub is spaced proximal to the proximal end surface of the proximal end of the body of the core member (Fig. 4 cannula 59 disposed through the hub, core, and carrier); and a cannula carrier having a head portion (Fig. 4 member 53 connected to the core via engagement), wherein the core member is connected to the cannula, wherein the cannula carrier is connected to the core member, and wherein the cannula carrier is controllably separable from the hub (Figs. 1 and 2 the needle, cannula, and carrier move together and are separable from the hub). Satchell does not teach the carrier to have a plurality of leg portions. However, Schraga teaches a threaded cannula carrier which has a plurality of legs which flex outwardly to allow the carrier to be threaded onto the injector as well as inserted and removed in additional fashions which do not include rotation and may enhance safety (Figs. 11- 14 slots 16’’’ form legs which are connected via frangible portions which break when subjected to force to separate the legs from the hub, this would be capable of occurring depending on the force and movement from the subject [0005], [0079], [0081], [0082], [0085], [0086]). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to use a plurality of legs which can deflect radially outward in response to a radial force in Satchell as Schraga teaches this is beneficial for connecting the cannula carrier in a plurality of manners to enhance safety. Satchell teaches the core, cannula, and carrier move together but do not explicitly recite how the core, cannula, and hub are attached. However, Monson et al. teach various connections include adhesives or press-fit ([0020], [0027]). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to non-removably connect the core, carrier, and cannula of Satchell with press fit or adhesive as Monson et al. teach this to be effective equivalents for a secure connection and would yield the same predictable result. With regard to claim 10, the proximal end of 54 is adjacent the shoulder in the area where 52 connects to 51 (Fig. 4), as combined this is where the proximal end of the leg surface would be located. Claim(s) 13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Satchell (US 3,736,932), Schraga (US 2012/0123334 A1), and Monson et al. (US 2009/0312715 A1) as applied to claim 12 above, and further in view of Bennwik et al. (US 5,709,659). With regard to claim 13, Satchell teaches a device substantially as claimed. Satchell does not disclose the cannula is configured to bend or break. However, Bennwik et al. teach permanently detaching the carrier from the hub of a syringe to break the needle to prevent reuse (abstract, Figs. 5). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to configure the cannula of Satchell to break as in Bennwik et al. as this is beneficial for preventing re-use. Claim(s) 14-17 and 19-21 is/are rejected under 35 U.S.C. 103 as being unpatentable over Knutson (US 2008/0171982 A1) in view of Zhao (US 2012/0150128 A1). With regard to claims 14, 16, 17, 20, and 21, Knutson teaches a subassembly of a hypodermic interface assembly, the subassembly comprising: a hub having a distal-most end surface (Fig. 5 member 14); a core member having a body defined by a proximal end having a proximal end surface and a distal end having a distal end surface (Fig. 5 member 10); and a cannula that is non-removably connected to the core member and the hub such that the cannula is not permitted to axially shift relative to the core member or the hub, wherein a portion of the cannula extends in a distal direction from the distal-most end surface of the hub to and in a proximal direction from the proximal end surface of the proximal end of the body of the core member, and wherein the distal-most end surface of the hub is spaced proximal to the proximal end surface of the proximal end of the body of the core member (Fig. 1 member 12, member 10 may be glued or soldered, [0033]). Knutson does not explicitly recite how the hub and cannula are connected. However, Zhao teaches adhesive may be used to secure a cannula within a core and hub and to secure a core to a hub (Fig. 4, adhesive secures core 44 to a hub, [0024]). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to non-removably connect the hub and cannula of Knutson as Zhao teach such to be an art effective connection means for fixation and would yield the same predictable result. With regard to claim 15, the passage diameter is necessarily slightly greater to accommodate the cannula. With regard to claim 19, the outer surface of 10 is taken as deformed at least in the area of connection to 24, further the transition from the faces to the side is taken as a deformation. Claim(s) 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Knutson (US 2008/0171982 A1) and Zhao (US 2012/0150128 A1) as applied to claim 15 above, and further in view of Sullivan et al. (US 2018/0021526 A1). With regard to claim 18, Knutson do not disclose the cannula receiving passage of the core is non-constant along the length. Zhao as combined to teach the adhesive in the passage appears to show the passage as non-constant, see the end where the needle extends through distally, but it is not explicitly discussed. However, Sullivan et al. teach the distal end opening diameter is larger to form a well for the adhesive (Fig. 8, [0059], [0063]). It would have been obvious to a person having ordinary skill before the effective filing date of the claimed invention to use a non-constant passage diameter in Knutson as Sullivan et al. teach this is beneficial for filling the passage with adhesive. Allowable Subject Matter Claim 11 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Response to Arguments Applicant’s arguments with respect to the claim(s) have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. The newly amended limitations are addressed as above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to EMILY L SCHMIDT whose telephone number is (571)270-3648. The examiner can normally be reached Monday through Thursday 7:00 AM to 4:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EMILY L SCHMIDT/ Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Show 5 earlier events
Feb 04, 2026
Response Filed
Mar 11, 2026
Final Rejection mailed — §103
May 11, 2026
Response after Non-Final Action
Jun 03, 2026
Request for Continued Examination
Jun 08, 2026
Applicant Interview (Telephonic)
Jun 09, 2026
Examiner Interview Summary
Jun 11, 2026
Response after Non-Final Action
Sep 30, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766264
NEEDLE-FREE INTRADERMAL INJECTION DEVICE
4y 12m to grant Granted Oct 20, 2026
Patent 12758747
NEUROSURGICAL APPARATUS AND METHODS
2y 8m to grant Granted Oct 13, 2026
Patent 12752059
INJECTION DEVICE AND A REUSABLE PART THEREFOR
4y 1m to grant Granted Oct 06, 2026
Patent 12741098
DEVICES AND METHODS FOR PRECISION DOSE DELIVERY
4y 2m to grant Granted Sep 22, 2026
Patent 12741123
SAFETY IV CATHETER WITH V-CLIP INTERLOCK AND NEEDLE TIP CAPTURE
3y 11m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
58%
Grant Probability
95%
With Interview (+36.6%)
3y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1018 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month